A Double-Blind, Randomised, Placebo Controlled, Adaptive Design Study of the Efficacy, Safety and Pharmacokinetics of NT-814 in Female Subjects With Moderate to Severe Vasomotor Symptoms Associated With the Menopause

Name: A Double-Blind, Randomised, Placebo Controlled, Adaptive Design Study of the Efficacy, Safety and Pharmacokinetics of NT-814 in Female Subjects With Moderate to Severe Vasomotor Symptoms Associated With the Menopause
Creator: Vivli
Published: 2025-12-19 16:02:28
License: 暂无描述

DataCite Commons2025-12-19 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012448/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to determine the effectiveness of BAY3427080 (NT-814), taken once a day, in the treatment of troublesome post-menopausal symptoms.

提供机构：

Vivli

创建时间：

2025-12-19